The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical significance of anti-p53 antibody in the sera in patients with breast cancer.
Y. Yamamoto
No relevant relationships to disclose
S. Yamamoto
No relevant relationships to disclose
M. Ibusuki
No relevant relationships to disclose
M. Hayashi
No relevant relationships to disclose
M. Tomiguchi
No relevant relationships to disclose
K. Murakami
No relevant relationships to disclose
H. Iwase
No relevant relationships to disclose